Literature DB >> 32445357

A Novel Cell-Free Fluorescent Assay for HDL Function: Low Apolipoprotein A1 Exchange Rate Associated with Increased Incident Cardiovascular Events.

Shuhui Wang Lorkowski1, Gregory Brubaker1, Lin Li1, Xinmin S Li1, Stanley L Hazen1,2, Jonathan D Smith1,2.   

Abstract

BACKGROUND: Cholesterol efflux capacity is a tissue culture assay for HDL function that is not amenable for high-throughput monitoring of risk assessment.
METHODS: We devised a cell-free HDL function assay to measure the exchange rate of exogenous apoA1 into serum HDL using NBD/Alexa647 double-labeled apoA1, whose NBD/Alexa647 emission ratio increased upon exchange into HDL. ApoA1 exchange rate (AER) was assayed by incubating labeled apoA1 with human serum, and the rate of the increase of the NBD/Alexa647 ratio over time was calculated as AER.
RESULTS: Fast protein liquid chromatography analysis of serum confirmed that the labeled apoA1 selectively exchanged into the HDL lipoprotein fraction. Characterization studies demonstrated that the AER assay had excellent intra- and inter-day reproducibility, was stable over 3 freeze-thaw cycles, and yielded similar results with serum or plasma. We quantified AER in serum from randomly selected stable subjects undergoing elective diagnostic coronary angiography (n = 997). AER was correlated with HDL-cholesterol (r = 0.58, P < 0.0001) and apoA1 levels (r = 0.56, P < 0.0001). Kaplan-Meier survival plot showed subjects in the lowest quartile of AER experienced a significantly higher rate of incident major adverse cardiovascular events (MACE = myocardial infarction, stroke, or death) (P < 0.0069 log rank). Moreover, compared to subjects in the lowest AER quartile, the remaining subjects showed significantly lower incident (3 year) risk for MACE, even after adjustment for traditional risk factors and apoA1 (HR 0.58; 95% CI 0.40-0.85; P = 0.005).
CONCLUSIONS: In a prospective cohort of stable subjects undergoing elective diagnostic cardiac evaluations, low AER was associated with increased incident risk of MACE. © American Association for Clinical Chemistry 2020. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  ApoA1 exchange rate; HDL; major adverse cardiovascular events

Mesh:

Substances:

Year:  2020        PMID: 32445357      PMCID: PMC7192547          DOI: 10.1093/jalm/jfaa002

Source DB:  PubMed          Journal:  J Appl Lab Med        ISSN: 2475-7241


  28 in total

1.  Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities.

Authors:  Laurent Camont; Marie Lhomme; Fabiana Rached; Wilfried Le Goff; Anne Nègre-Salvayre; Robert Salvayre; Catherine Calzada; Michel Lagarde; M John Chapman; Anatol Kontush
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-10-03       Impact factor: 8.311

2.  Kinetic and thermodynamic analyses of spontaneous exchange between high-density lipoprotein-bound and lipid-free apolipoprotein A-I.

Authors:  Daisuke Handa; Hitoshi Kimura; Tatsuya Oka; Yuki Takechi; Keiichiro Okuhira; Michael C Phillips; Hiroyuki Saito
Journal:  Biochemistry       Date:  2015-01-16       Impact factor: 3.162

3.  Exchange of apolipoprotein A-I between lipid-associated and lipid-free states: a potential target for oxidative generation of dysfunctional high density lipoproteins.

Authors:  Giorgio Cavigiolio; Ethan G Geier; Baohai Shao; Jay W Heinecke; Michael N Oda
Journal:  J Biol Chem       Date:  2010-04-12       Impact factor: 5.157

4.  Development and Validation of Apolipoprotein AI-Associated Lipoprotein Proteome Panel for the Prediction of Cholesterol Efflux Capacity and Coronary Artery Disease.

Authors:  Zhicheng Jin; Timothy S Collier; Darlene L Y Dai; Virginia Chen; Zsuzsanna Hollander; Raymond T Ng; Bruce M McManus; Robert Balshaw; Sophia Apostolidou; Marc S Penn; Cory Bystrom
Journal:  Clin Chem       Date:  2018-11-21       Impact factor: 8.327

5.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

6.  Double superhelix model of high density lipoprotein.

Authors:  Zhiping Wu; Valentin Gogonea; Xavier Lee; Matthew A Wagner; Xin-Min Li; Ying Huang; Arundhati Undurti; Roland P May; Michael Haertlein; Martine Moulin; Irina Gutsche; Giuseppe Zaccai; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2009-10-07       Impact factor: 5.157

7.  ABCA1 mediates unfolding of apolipoprotein AI N terminus on the cell surface before lipidation and release of nascent high-density lipoprotein.

Authors:  Shuhui Wang; Kailash Gulshan; Gregory Brubaker; Stanley L Hazen; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-04       Impact factor: 8.311

8.  Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity.

Authors:  Svetlana A Didichenko; Alexei V Navdaev; Alexandre M O Cukier; Andreas Gille; Patrick Schuetz; Martin O Spycher; Patrice Thérond; M John Chapman; Anatol Kontush; Samuel D Wright
Journal:  Circ Res       Date:  2016-07-19       Impact factor: 17.367

9.  Association Between Serum High-Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW-CKD.

Authors:  Ki Heon Nam; Tae Ik Chang; Young Su Joo; Joohwan Kim; Sangmi Lee; Changhyun Lee; Hae-Ryong Yun; Jung Tak Park; Tae-Hyun Yoo; Su Ah Sung; Kyu-Beck Lee; Kook-Hwan Oh; Soo Wan Kim; Joongyub Lee; Shin-Wook Kang; Kyu Hun Choi; Curie Ahn; Seung Hyeok Han
Journal:  J Am Heart Assoc       Date:  2019-03-19       Impact factor: 5.501

10.  Validation and application of a novel cholesterol efflux assay using immobilized liposomes as a substitute for cultured cells.

Authors:  Yuna Horiuchi; Shao-Jui Lai; Azusa Yamazaki; Ayaka Nakamura; Ryunosuke Ohkawa; Kouji Yano; Takahiro Kameda; Shigeo Okubo; Shitsuko Shimano; Michio Hagihara; Shuji Tohda; Minoru Tozuka
Journal:  Biosci Rep       Date:  2018-04-13       Impact factor: 3.840

View more
  3 in total

1.  Decreased Triglyceride and Increased Serum Lipoprotein Lipase Levels Are Correlated to Increased High-Density Lipoprotein-Cholesterol Levels after Laparoscopic Sleeve Gastrectomy.

Authors:  Masahiro Ohira; Yasuhiro Watanabe; Takashi Yamaguchi; Hiroki Onda; Shuhei Yamaoka; Kazuki Abe; Shoko Nakamura; Sho Tanaka; Naoyuki Kawagoe; Taiki Nabekura; Takashi Oshiro; Daiji Nagayama; Ichiro Tatsuno; Atsuhito Saiki
Journal:  Obes Facts       Date:  2021-10-11       Impact factor: 3.942

Review 2.  Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function.

Authors:  Julia T Stadler; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

Review 3.  HDL Is Not Dead Yet.

Authors:  Shuhui Wang Lorkowski; Jonathan D Smith
Journal:  Biomedicines       Date:  2022-01-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.